Alterity Therapeutics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ATHE

Based on 1 analyst offering 12 month price targets for Alterity Therapeutics Ltd.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell ATHE stock?

Based on 1 analyst offering ratings for Alterity Therapeutics Ltd.
Strong Buy
Strong Buy
1 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATHE stock forecasts and price targets.

ATHE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Ladenburg Thalmann
Bottom 4%
Strong BuyMaintains$10.00+277.36%2023-06-05

1 of 1

ATHE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHE$2.65$10.00+277.36%Strong Buy

Alterity Therapeutics Stock Forecast FAQ

Is Alterity Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ATHE) stock is to Strong Buy ATHE stock.

Out of 1 analyst, 1 (100%) are recommending ATHE as a Strong Buy, 0 (0%) are recommending ATHE as a Buy, 0 (0%) are recommending ATHE as a Hold, 0 (0%) are recommending ATHE as a Sell, and 0 (0%) are recommending ATHE as a Strong Sell.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is ATHE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ATHE price target, the average ATHE price target is $10.00, with the highest ATHE stock price forecast at $10.00 and the lowest ATHE stock price forecast at $10.00.

The Wall Street analyst predicted that Alterity Therapeutics's share price could reach $10.00 by Jun 5, 2024. The average Alterity Therapeutics stock price prediction forecasts a potential upside of 277.36% from the current ATHE share price of $2.65.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.